Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_assertion type Assertion NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_head.
- NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_assertion description "[Despite the evidence of early insulin treatment lowering macrovascular (coronary artery disease, peripheral arterial disease and stroke) and microvascular (diabetic nephropathy, neuropathy and retinopathy) complications of T2DM, controversy exists among physicians on how to initiate and intensify insulin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_provenance.
- NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_assertion evidence source_evidence_literature NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_provenance.
- NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_assertion SIO_000772 23584214 NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_provenance.
- NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_assertion wasDerivedFrom befree-2016 NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_provenance.
- NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_assertion wasGeneratedBy ECO_0000203 NP1069083.RAj_JX7RzRf5DJm65UYui7QqIJy3F2nTPVuCelmjzdKXg130_provenance.